No Prescription |
 |
 | ||
|
Baclazone INHLR Generic Beclometasone |
|
| ||
No Prescription » Prescription Drugs 2 » Baclazone INHLR Generic Beclometasone Beclazone is used to help prevent asthma. Beclazone contains a medicine called beclometasone dipropionate which belongs to a family of medicines called corticosteroids. Inhaled corticosteroids are not the same as anabolic steroids which some athletes and body-builder use. Your Beclazone Inhaler delivers very small amounts of inhaled corticosteroid straight to your lungs where it works by reducing inflammation (swelling and irritation) in the small airways. This helps you to breathe easier and helps to prevent asthma attacks. This kind of medicine is known as a 'Preventer'. It must be used everyday as directed by your doctor even if you have no asthma symptoms.Beclazone may take a few days to start to work. Do not stop using your inhaler unless a doctor tells you to. Beclazone does not give immediate relief from an asthma attack. Do not use Beclazone to relieve wheezing or breathlessness - you may have been given a different kind of inhaler medicine called a 'Reliever' for that. Your doctor may have told you to use a Reliever inhaler in addition to your Beclazone Inhaler.There is no evidence that Beclazone Inhaler is addictive.How to use Beclomethasone Dipropionate InhlFirst read the manufacturers instruction leaflet provided by your pharmacist before you start using beclomethasone and each time you get a refill. If you have any questions consult your doctor or pharmacist.This medication is inhaled into the lungs using a special inhaler device. Using this inhaler device with a spacer makes it easier to inhale the medication. To use the inhaler shake the canister for about 10 seconds. Take a drink of water to moisten the throat. Place the inhaler or spacer mouthpiece into your mouth over the tongue. Close your lips tightly around the mouthpiece. Press the inhaler while taking a slow deep breath through your mouth for 5 seconds. Hold your breath for 10 seconds while keeping the inhaler in your mouth so that the drug can be absorbed into the lungs. Remove the inhaler device from your mouth and slowly breathe out.Use this medication twice daily or as directed by your doctor. The dosage is based on your medical condition and response to therapy.If 2 or more inhalations/puffs for each dose are prescribed wait at least 1 minute between them.If you are using other inhalers at the same time use them first. Wait several minutes between the use of those inhalers and beclomethasone.To prevent dry mouth hoarseness and fungal infection of the mouth rinse your mouth with water after each use. Do not swallow the rinse water.Take this medication exactly as prescribed. Follow the dosing schedule carefully. If you have any questions ask your doctor or pharmacist.If you have been taking high doses of this medication for a long time do not suddenly stop taking it without your doctor's approval. Some conditions may become worse when this drug is suddenly stopped. Your dose may need to be gradually decreased to reduce symptoms such as extreme tiredness weakness weight loss or nausea. Tell your doctor immediately if any of these symptoms occur after stopping the medication. Buy Baclazone INHLR Generic Beclometasone and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Baclazone INHLR Generic Beclometasone: Product Type: Prescription Drugs 2 Baclazone INHLR ( Generic Beclometasone ) Baclazone INHLR (Generic Beclometasone) Generic Beclometasone 100mcg 3 x 200 Dose 100mcg 200 dose 250mcg 200 Dose 250mcg 3 x 200 Dose 50mcg 200 Dose 50mcg 3 x 200 Dose Generic Beclometasone Baclazone INHLR
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
